AIRLINK 186.40 Increased By ▲ 1.71 (0.93%)
BOP 12.69 Decreased By ▼ -0.09 (-0.7%)
CNERGY 7.60 Decreased By ▼ -0.21 (-2.69%)
FCCL 40.50 Decreased By ▼ -0.34 (-0.83%)
FFL 14.90 Decreased By ▼ -0.28 (-1.84%)
FLYNG 27.31 Increased By ▲ 0.37 (1.37%)
HUBC 130.97 Decreased By ▼ -0.10 (-0.08%)
HUMNL 13.25 Decreased By ▼ -0.57 (-4.12%)
KEL 4.47 Decreased By ▼ -0.04 (-0.89%)
KOSM 6.04 Decreased By ▼ -0.10 (-1.63%)
MLCF 53.44 Increased By ▲ 2.21 (4.31%)
OGDC 212.50 Increased By ▲ 0.39 (0.18%)
PACE 6.09 Decreased By ▼ -0.20 (-3.18%)
PAEL 41.85 Decreased By ▼ -0.70 (-1.65%)
PIAHCLA 15.91 Decreased By ▼ -0.60 (-3.63%)
PIBTL 9.58 Increased By ▲ 0.64 (7.16%)
POWER 11.10 No Change ▼ 0.00 (0%)
PPL 173.00 Decreased By ▼ -2.00 (-1.14%)
PRL 34.02 Decreased By ▼ -0.71 (-2.04%)
PTC 23.35 Decreased By ▼ -0.59 (-2.46%)
SEARL 87.40 Decreased By ▼ -7.02 (-7.43%)
SILK 1.13 Decreased By ▼ -0.01 (-0.88%)
SSGC 32.41 Decreased By ▼ -0.70 (-2.11%)
SYM 15.65 Decreased By ▼ -1.46 (-8.53%)
TELE 7.99 Decreased By ▼ -0.26 (-3.15%)
TPLP 11.04 Decreased By ▼ -0.41 (-3.58%)
TRG 59.50 Decreased By ▼ -0.75 (-1.24%)
WAVESAPP 11.28 Decreased By ▼ -0.11 (-0.97%)
WTL 1.41 Decreased By ▼ -0.04 (-2.76%)
YOUW 3.81 Decreased By ▼ -0.12 (-3.05%)
AIRLINK 186.40 Increased By ▲ 1.71 (0.93%)
BOP 12.69 Decreased By ▼ -0.09 (-0.7%)
CNERGY 7.60 Decreased By ▼ -0.21 (-2.69%)
FCCL 40.50 Decreased By ▼ -0.34 (-0.83%)
FFL 14.90 Decreased By ▼ -0.28 (-1.84%)
FLYNG 27.31 Increased By ▲ 0.37 (1.37%)
HUBC 130.97 Decreased By ▼ -0.10 (-0.08%)
HUMNL 13.25 Decreased By ▼ -0.57 (-4.12%)
KEL 4.47 Decreased By ▼ -0.04 (-0.89%)
KOSM 6.04 Decreased By ▼ -0.10 (-1.63%)
MLCF 53.44 Increased By ▲ 2.21 (4.31%)
OGDC 212.50 Increased By ▲ 0.39 (0.18%)
PACE 6.09 Decreased By ▼ -0.20 (-3.18%)
PAEL 41.85 Decreased By ▼ -0.70 (-1.65%)
PIAHCLA 15.91 Decreased By ▼ -0.60 (-3.63%)
PIBTL 9.58 Increased By ▲ 0.64 (7.16%)
POWER 11.10 No Change ▼ 0.00 (0%)
PPL 173.00 Decreased By ▼ -2.00 (-1.14%)
PRL 34.02 Decreased By ▼ -0.71 (-2.04%)
PTC 23.35 Decreased By ▼ -0.59 (-2.46%)
SEARL 87.40 Decreased By ▼ -7.02 (-7.43%)
SILK 1.13 Decreased By ▼ -0.01 (-0.88%)
SSGC 32.41 Decreased By ▼ -0.70 (-2.11%)
SYM 15.65 Decreased By ▼ -1.46 (-8.53%)
TELE 7.99 Decreased By ▼ -0.26 (-3.15%)
TPLP 11.04 Decreased By ▼ -0.41 (-3.58%)
TRG 59.50 Decreased By ▼ -0.75 (-1.24%)
WAVESAPP 11.28 Decreased By ▼ -0.11 (-0.97%)
WTL 1.41 Decreased By ▼ -0.04 (-2.76%)
YOUW 3.81 Decreased By ▼ -0.12 (-3.05%)
BR100 11,869 Decreased By -51.1 (-0.43%)
BR30 35,588 Decreased By -219.5 (-0.61%)
KSE100 113,252 Decreased By -532.6 (-0.47%)
KSE30 35,194 Decreased By -193.2 (-0.55%)
Business & Finance

Brazil's Embraer jet deliveries rise, backlog falls

  • The backlog now stands at $14.2 billion, down from $15.9 billion in the first quarter of 2020.
  • Embraer, the world's No. 3 planemaker, has been deeply challenged by the pandemic, along with its larger competitors Boeing Co and Airbus SE.
Published April 27, 2021

Brazilian planemaker Embraer SA said it delivered 22 jets in the first quarter, up from 14 jets a year ago when the pandemic was beginning to erode air travel demand, but cutting into its backlog, which measures future revenue.

The backlog now stands at $14.2 billion, down from $15.9 billion in the first quarter of 2020.

Embraer, the world's No. 3 planemaker, has been deeply challenged by the pandemic, along with its larger competitors Boeing Co and Airbus SE.

While Embraer executives have said repeatedly that clients have not canceled jet orders due to the pandemic, the planemaker is struggling to secure new orders for its commercial jets.

Embraer did not add any new firm commercial jet orders in the past three months and had only two orders in the past year, the company's numbers show.

Embraer's pending firm orders for commercial planes stand at 272 as of March 31, the planemaker said, down from 281 firm orders on Dec. 31.

Embraer does not disclose detailed information on its pending firm orders for corporate jets or its defense products.

Shares in the planemaker, which will release quarterly results on Thursday, fell 0.7%.

Comments

Comments are closed.